A former pharmaceutical sales representative for Orphan Medical, Alfred Caronia was responsible for promoting the company’s narcolepsy drug Xyrem. A whistleblower accused Caronia and a company speaker ...

The use of antipsychotic medications for purposes other than those officially approved is common among older adults in Finland. This emerges from a large registry study conducted by the University of ...

A consensus statement providing novel guidance for use of GLP-1 and GLP-1/GIP receptor agonists (GLP-1s and GIP/GLP-1s) in management of type 1 diabetes (T1D) was published today in Diabetes ...

It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help! Some clinicians are incorporating off-label HER2-targeted therapies in ...

Off‐label drug use in children refers to the prescribing of medicines outside the terms of their licensed marketing authorisation, whether by age, dosage, indication or route. It arises from a chronic ...

Insulin therapy is a lifesaving necessity for people with type 1 diabetes, and its essentially the only medication approved for managing the condition. But a variety of additional blood-sugar-lowering ...

The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

Every day in medical offices around the country, physicians hand patients prescriptions for drugs to treat conditions for which the medicines haven't been approved. Once a drug is approved by the Food ...

May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...

A large registry study in Finland by the University of Oulu and the University of Eastern Finland shows that many older adults receive antipsychotic medications for purposes other than those ...